Erlotinib hydrochloride, EGFR tyrosine kinase inhibitor
Be the first to review this product! Submit a review
|
(6 Publications)
MW 429.9 Da, Purity >98%. Potent EGFR tyrosine kinase inhibitor (IC50 = 2 nM). Decreases EGFR autophosphorylation in tumor cells. Potent inhibitor of mutant JAK2-V617F. Weaker inhibitor of ErbB-2 kinase (Ki = 1 μM) and ErbB-4 kinase (Ki = 1.5 μM). Clinically effective agent for non-small cell lung cancer (NSCLC).
View Alternative Names
94 kDa B raf protein, Avian erythroblastic leukemia viral (v erb b) oncogene homolog, B Raf proto oncogene serine threonine protein kinase, B Raf proto oncogene, serine/threonine kinase, B raf 1, B-Raf proto-oncogene serine/threonine-protein kinase (p94), BRAF_HUMAN, C erb B2/neu protein, CD340, CD340 antigen, Cell growth inhibiting protein 40, Cell proliferation inducing protein 61, CerbB2, EGFR_HUMAN, ERBB, ERBB1, ERBB2_HUMAN, Epidermal growth factor receptor, Epidermal growth factor receptor (avian erythroblastic leukemia viral (v erb b) oncogene homolog), Epidermal growth factor receptor (erythroblastic leukemia viral (v erb b) oncogene homolog avian), Erb b2 receptor tyrosine kinase 2, ErbB-2 proto-oncogene, Errp, FLJ95109, HER 2, HER 2/NEU, HER1, Herstatin, Human epidermal growth factor receptor 2, MGC126806, MGC138284, MLN 19, Metastatic lymph node gene 19 protein, Murine sarcoma viral (v-raf) oncogene homolog B1, Murine sarcoma viral v raf oncogene homolog B1, NEU, NEU proto oncogene, NGL, NISBD2, NS7, Neuro/glioblastoma derived oncogene homolog, Neuroblastoma/glioblastoma derived oncogene homolog, Oncogen BRAF, Oncogen ERBB, PIG61, Proto-oncogene B-Raf, Proto-oncogene Neu, Proto-oncogene c-ErbB-1, Proto-oncogene c-ErbB-2, Proto-oncogene c-Rmil, RAF, RAFB 1, RMIL, Receptor tyrosine-protein kinase ErbB-1, Receptor tyrosine-protein kinase erbB-2, SA7, Serine/threonine-protein kinase B-raf, Species antigen 7, TKR1, Tyrosine kinase-type cell surface receptor HER2, Urogastrone, V erb b2 avian erythroblastic leukemia viral oncogene homolog 2, V erb b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog), V erb b2 avian erythroblastic leukemia viral oncoprotein 2, V erb b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog, V erb b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian), Verb b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived-oncogene homolog, Wa5, cRmil, erb-b2 receptor tyrosine kinase 1, mENA, oncogene BRAF1, p185erbB2, p94, v raf murine sarcoma viral oncogene homolog B, v-Raf murine sarcoma viral oncogene homolog B1, v-erb-b Avian erythroblastic leukemia viral oncogen homolog, wa2
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Redox biology 69:102976 PubMed38052106
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 10:1075364 PubMed36605723
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biochemistry and biophysics reports 22:100763 PubMed32322693
2020
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 15:957 PubMed26673416
2015
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 10:e0120405 PubMed25793970
2015
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 14:2171-80 PubMed25714397
2015
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com